V-0219 is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R), can be used for obesity-associated diabetes research.
[1] Decara JM, et al. J Med Chem. 2022 Apr 14;65(7):5449-5461.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 5mg | ¥1,090.00 | 现货 | 1 | |
| 25mg | ¥3,268.00 | 现货 | 1 |
















V-0219 is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R), can be used for obesity-associated diabetes research.
[1] Decara JM, et al. J Med Chem. 2022 Apr 14;65(7):5449-5461.